These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33651776)

  • 1. Attitudes towards and use of cannabis in New Zealand patients with inflammatory bowel disease: an exploratory study.
    Appleton K; Whittaker E; Cohen Z; Rhodes HM; Dunn C; Murphy S; Gaastra M; Galletly A; Dougherty S; Haren A; Sukumaran N; Aluzaite K; Dockerty JD; Turner RM; Schultz M
    N Z Med J; 2021 Feb; 134(1530):38-47. PubMed ID: 33651776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis use amongst patients with inflammatory bowel disease.
    Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
    Hansen TM; Sabourin BC; Oketola B; Bernstein CN; Singh H; Targownik LE
    Inflamm Bowel Dis; 2020 Aug; 26(9):1401-1406. PubMed ID: 31725152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.
    Storr M; Devlin S; Kaplan GG; Panaccione R; Andrews CN
    Inflamm Bowel Dis; 2014 Mar; 20(3):472-80. PubMed ID: 24407485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes towards antidepressants among people living with inflammatory bowel disease: an online Australia-wide survey.
    Mikocka-Walus A; Andrews JM
    J Crohns Colitis; 2014 Apr; 8(4):296-303. PubMed ID: 24074632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study.
    Glickman D; Dalessio S; Raup-Konsavage WM; Vrana KE; Coates MD
    Inflamm Bowel Dis; 2024 Jul; 30(7):1055-1061. PubMed ID: 37580878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring medicinal use of cannabis in a time of policy change in New Zealand.
    Rychert M; Wilkins C; Parker K; Graydon-Guy T
    N Z Med J; 2020 May; 133(1515):54-69. PubMed ID: 32438377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease.
    Coates MD; Dalessio S; Walter V; Stuart A; Bernasko N; Tinsley A; Razeghi S; Williams ED; Clarke K; Vrana K
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):445-450. PubMed ID: 33998892
    [No Abstract]   [Full Text] [Related]  

  • 9. Marijuana use patterns among patients with inflammatory bowel disease.
    Ravikoff Allegretti J; Courtwright A; Lucci M; Korzenik JR; Levine J
    Inflamm Bowel Dis; 2013 Dec; 19(13):2809-14. PubMed ID: 24185313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
    Pittet VEH; Maillard MH; Simonson T; Fournier N; Rogler G; Michetti P;
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2050-2059.e1. PubMed ID: 30471455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey.
    Neufeld T; Pfuhlmann K; Stock-Schröer B; Kairey L; Bauer N; Häuser W; Langhorst J
    Z Gastroenterol; 2021 Oct; 59(10):1068-1077. PubMed ID: 34157755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical marijuana for inflammatory bowel disease: the highs and lows.
    Wynne J; Kozuch P
    Scand J Gastroenterol; 2022 Feb; 57(2):197-205. PubMed ID: 34919496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, Perception, and Use of Cannabis Therapy in Patients with Inflammatory Bowel Disease.
    Muñiz-Camacho LA; Negrón-Quintana FI; Ramos-Burgos LA; Cruz-Cruz JJ; Torres EA
    P R Health Sci J; 2021 Sep; 40(3):110-114. PubMed ID: 34792923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study.
    Gearry RB; Richardson A; Frampton CM; Collett JA; Burt MJ; Chapman BA; Barclay ML
    Inflamm Bowel Dis; 2006 Oct; 12(10):936-43. PubMed ID: 17012964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.
    Kochar B; Martin CF; Kappelman MD; Spiegel BM; Chen W; Sandler RS; Long MD
    Am J Gastroenterol; 2018 Jan; 113(1):72-79. PubMed ID: 28853727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
    Carvalho ACA; Souza GA; Marqui SV; Guiguer ÉL; Araújo AC; Rubira CJ; Goulart RA; Flato UAP; Bueno PCDS; Buchaim RL; Barbalho SM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis.
    Amiesimaka OI; Allemann SS; Braund R; Schultz M; Aluzaite K
    Br J Clin Pharmacol; 2024 Aug; 90(8):1911-1920. PubMed ID: 38689379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients.
    Benson MJ; Abelev SV; Connor SJ; Corte CJ; Martin LJ; Gold LK; Suraev AS; McGregor IS
    Crohns Colitis 360; 2020 Apr; 2(2):otaa015. PubMed ID: 36777301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease [IBD] and Physical Activity: A Study on the Impact of Diagnosis on the Level of Exercise Amongst Patients With IBD.
    Gatt K; Schembri J; Katsanos KH; Christodoulou D; Karmiris K; Kopylov U; Pontas C; Koutroubakis IE; Foteinogiannopoulou K; Fabian A; Molnar T; Zammit D; Fragaki M; Balomenos D; Zingboim N; Ben Horin S; Mantzaris GJ; Ellul P
    J Crohns Colitis; 2019 May; 13(6):686-692. PubMed ID: 30561568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.